Works matching IS 10781552 AND DT 2016 AND VI 22 AND IP 6
Results: 13
Abstracts from the Global Pharmacy and Health Care Services Research Summit (GPHSRS) 2016.
- Published in:
- 2016
- Publication type:
- Abstract
Low rate of cetuximab hypersensitivity reactions in Northeast Tennessee: An Appalachian effect?
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 784, doi. 10.1177/1078155215618771
- By:
- Publication type:
- Article
Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 777, doi. 10.1177/1078155215612541
- By:
- Publication type:
- Article
Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 806, doi. 10.1177/1078155215611048
- By:
- Publication type:
- Article
Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunction.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 811, doi. 10.1177/1078155215610916
- By:
- Publication type:
- Article
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 766, doi. 10.1177/1078155215610915
- By:
- Publication type:
- Article
Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 771, doi. 10.1177/1078155215609987
- By:
- Publication type:
- Article
Effect of ceftriaxone and cefepime on high-dose methotrexate clearance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 801, doi. 10.1177/1078155215608524
- By:
- Publication type:
- Article
Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 741, doi. 10.1177/1078155215608523
- By:
- Publication type:
- Article
Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 795, doi. 10.1177/1078155215607090
- By:
- Publication type:
- Article
Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 757, doi. 10.1177/1078155215607089
- By:
- Publication type:
- Article
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 749, doi. 10.1177/1078155215607088
- By:
- Publication type:
- Article
Activity of single-agent decitabine in atypical chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 790, doi. 10.1177/1078155215605662
- By:
- Publication type:
- Article